United States:
Innovative Exit Strategies In Life Sciences – Bill Whelan, Co-chair, Life Sciences Practice (Video Content)
To print this article, all you need is to be registered or login on Mondaq.com.
Bill Whelan discusses exit strategies in the life sciences.
Bill Whelan, Co-chair, Life Sciences Practice
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).